HLA genes, islet autoantibodies and residual C-peptide at the clinical onset of type 1 diabetes mellitus and the risk of retinopathy 15 years later.
<h4>Aims/hypothesis</h4>HLA genes, islet autoantibodies and residual C-peptide were studied to determine the independent association of each exposure with diabetic retinopathy (DR), 15 years after the clinical onset of type 1 diabetes in 15-34 year old individuals.<h4>Methods</h...
Guardado en:
Autores principales: | Richard A Jensen, Elisabet Agardh, Ake Lernmark, Soffia Gudbjörnsdottir, Nicholas L Smith, David S Siscovick, Carina Törn, DISS Group |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ec2519045a9d49c9b288e826b4223fc2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
High plasma levels of islet amyloid polypeptide in young with new-onset of type 1 diabetes mellitus.
por: Johan F Paulsson, et al.
Publicado: (2014) -
Autoantibody profiles and clinical association in Thai patients with autoimmune retinopathy
por: Aulia Rahmi Pawestri, et al.
Publicado: (2021) -
New-onset IgG autoantibodies in hospitalized patients with COVID-19
por: Sarah Esther Chang, et al.
Publicado: (2021) -
Integrative epigenomics in Sjögren´s syndrome reveals novel pathways and a strong interaction between the HLA, autoantibodies and the interferon signature
por: María Teruel, et al.
Publicado: (2021) -
Nine residues in HLA-DQ molecules determine with susceptibility and resistance to type 1 diabetes among young children in Sweden
por: Lue Ping Zhao, et al.
Publicado: (2021)